Unlock PARP Inhibition: The Role of 4-(4-Fluoro-3-(piperazine-1-carbonyl)benzyl)phthalazin-1(2H)-one in Targeted Cancer Therapy
Discover the vital pharmaceutical intermediate for next-generation cancer treatments.
Get a Quote & SampleProduct Core Value
4-(4-Fluoro-3-(piperazine-1-carbonyl)benzyl)phthalazin-1(2H)-one
This compound is a crucial pharmaceutical intermediate, instrumental in the synthesis of potent PARP-1 and PARP-2 inhibitors. Its high purity and specific chemical structure make it an indispensable building block for developing advanced targeted cancer therapies.
- Leveraging high purity pharmaceutical compounds for improved drug efficacy. Our 4-(4-fluoro-3-(piperazine-1-carbonyl)benzyl)phthalazin-1(2H)-one intermediate ensures the highest standards in your synthesis.
- Exploring the synthesis of PARP inhibitors with our CAS 763111-47-3 chemical. This compound is meticulously produced to meet the rigorous demands of modern pharmaceutical development.
- Advancing targeted cancer therapy through specialized chemical building blocks. Utilize this vital intermediate to unlock new therapeutic possibilities in oncology.
- Reliable sourcing of essential pharmaceutical intermediates for drug discovery. We provide the foundational elements for innovative pharmaceutical research and manufacturing.
Advantages Offered
Enhanced Therapeutic Efficacy
By utilizing high purity pharmaceutical compounds, researchers can achieve greater efficacy in their targeted cancer therapy synthesis, ensuring better patient outcomes.
Streamlined Synthesis Processes
Our CAS 763111-47-3 chemical is designed to simplify complex synthesis routes for PARP inhibitors, saving valuable time and resources in drug development.
Accelerated Drug Discovery
Access to reliable chemical building blocks like this intermediate significantly speeds up the drug discovery pipeline, bringing novel treatments to patients faster.
Key Applications
Pharmaceutical Synthesis
As a critical pharmaceutical intermediate, this compound is indispensable for the meticulous synthesis of active pharmaceutical ingredients (APIs) used in groundbreaking medical treatments.
Cancer Therapy Research
Its role in the development of PARP inhibitors positions it at the forefront of targeted cancer therapy research, offering new avenues for treating various forms of cancer.
Fine Chemical Production
This compound is a prime example of a fine chemical that enables precise molecular engineering, crucial for creating sophisticated therapeutic agents.
Drug Development Pipelines
Researchers and manufacturers rely on this chemical to ensure the quality and effectiveness of their drug development pipelines, from early-stage research to large-scale production.